Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

13899 items
12:19 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

Daewoong restructuring R&D

Daewoong Pharmaceutical Co. Ltd. (KSE:069620) said it is restructuring its R&D group. The company said the goal is to "expedite new drug development" and to strengthen three newly announced centers. The three centers will focus on...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

UC Regents get CRISPR guide RNA patent in U.S.

The U.S. Patent Office on June 19 granted a patent related to CRISPR-Cas9 gene editing technology to the Regents of the University of California, the University of Vienna and Emmanuelle Charpentier covering use of guide...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

NIH ends funding for alcohol study

NIH said it will stop funding the Moderate Alcohol and Cardiovascular Health (MACH) study after concluding that NIH employees violated agency policies to secure its funding and potentially biased its design towards the alcohol industry. Led...
11:08 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Other News

Gawande to head Amazon-Berkshire-Chase healthcare company

Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK.A; NYSE:BRK.B) and JPMorgan Chase & Co. (NYSE:JPM) hired Atul Gawande as CEO of their new company focused on U.S. employee healthcare, effective July 9. His experience draws from...
1:22 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Other News

Eisai to open U.S.-based immunodementia discovery center

With a three-year $100 million investment, Eisai Inc. will launch the Eisai Center for Genetics Guided Dementia Discovery in Cambridge, Mass. Eisai Inc. is the U.S. subsidiary of Eisai Co. Ltd. (Tokyo:4523). The center, expected to...
1:15 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Other News

WuXi picks Massachusetts for first U.S. manufacturing site

WuXi Biologics Inc. (HKSE:2269) said it will invest $60 million to construct a biologics production facility in Worcester, Mass. The manufacturing site will be WuXi Biologics' first in the U.S., and 11th overall. The company plans...
9:20 AM, Jun 15, 2018  |  BC Week In Review | Company News  |  Other News

Acorda gains following Ampyra appeal arguments

Acorda Therapeutics Inc. (NASDAQ:ACOR) added over $117 million in market cap on June 8 following oral arguments held June 7 in its appeal of a district court ruling invalidating four of five patents for multiple...
8:30 AM, Jun 08, 2018  |  BC Week In Review | Company News  |  Other News

DRC approves compassionate use of investigational Ebola treatments

A Democratic Republic of the Congo ethics committee approved the use of five investigational Ebola therapies under compassionate use and expanded access. The World Health Organization said four of the five approved products are in the...
8:09 AM, Jun 08, 2018  |  BC Week In Review | Company News  |  Other News

Exact up on earlier colon cancer screening recommendation

Exact Sciences Corp. (NASDAQ:EXAS) jumped $5.86 (11%) to $58.58 on May 30 when the American Cancer Society (ACS) issued updated guidelines recommending that screening for colorectal cancer start earlier. Exact markets Cologuard, a non-invasive stool...
8:08 AM, Jun 08, 2018  |  BC Week In Review | Company News  |  Other News

Report highlights global biopharma interest in China

Ninety percent of global biopharma companies are interested in expanding to Asia, with 86% citing China specifically, according to a report from L.E.K. Consulting and BIO unveiled on June 4. Of the 88 biopharma executives...

Pages